A detailed history of Wilson & Boucher Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wilson & Boucher Capital Management, LLC holds 639 shares of LLY stock, worth $535,207. This represents 0.35% of its overall portfolio holdings.

Number of Shares
639
Previous 740 13.65%
Holding current value
$535,207
Previous $656 Million 24.75%
% of portfolio
0.35%
Previous 0.45%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 18, 2025

SELL
$727.2 - $932.06 $73,447 - $94,138
-101 Reduced 13.65%
639 $493 Million
Q3 2024

Nov 15, 2024

BUY
$772.14 - $960.02 $77,986 - $96,962
101 Added 15.81%
740 $656 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $189,915 - $238,168
262 Added 69.5%
639 $578 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $223,259 - $298,689
377 New
377 $294 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $796B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wilson & Boucher Capital Management, LLC Portfolio

Follow Wilson & Boucher Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilson & Boucher Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilson & Boucher Capital Management, LLC with notifications on news.